NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+5.74%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.25B
AUM Growth
+$2.25B
Cap. Flow
+$58.4M
Cap. Flow %
2.6%
Top 10 Hldgs %
71.88%
Holding
46
New
3
Increased
7
Reduced
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$595M 26.49% 10,420,555 +145,442 +1% +$8.31M
CRSP icon
2
CRISPR Therapeutics
CRSP
$4.71B
$159M 7.08% 3,484,464 +263,736 +8% +$12.1M
ADAP
3
Adaptimmune Therapeutics
ADAP
$15.6M
$150M 6.66% 13,332,611 +1,306,612 +11% +$14.7M
CBIO
4
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$139M 6.2% 8,584,128
MRSN icon
5
Mersana Therapeutics
MRSN
$36.5M
$128M 5.71% 8,144,267
EPZM
6
DELISTED
Epizyme, Inc
EPZM
$115M 5.1% 6,460,851
RYTM icon
7
Rhythm Pharmaceuticals
RYTM
$6.85B
$97.8M 4.35% 4,912,306
SENS icon
8
Senseonics Holdings
SENS
$374M
$92.7M 4.12% 30,888,266
ARDX icon
9
Ardelyx
ARDX
$1.53B
$71.1M 3.16% 14,083,582
AKAO
10
DELISTED
Achaogen, Inc.
AKAO
$67.5M 3% 5,215,128
OBSV
11
DELISTED
ObsEva SA Ordinary Shares
OBSV
$61.9M 2.75% 4,586,563
AVEO
12
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$47.5M 2.11% 16,362,694
XFOR icon
13
X4 Pharmaceuticals
XFOR
$84.2M
$45.8M 2.04% 2,000,000
IMMU
14
DELISTED
Immunomedics Inc
IMMU
$40.5M 1.8% 2,772,643
SYBX icon
15
Synlogic
SYBX
$17M
$39.7M 1.76% 4,229,410 +410,000 +11% +$3.85M
SBBP
16
DELISTED
Strongbridge Biopharma plc.
SBBP
$36.7M 1.63% 4,141,308
CMTA
17
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$32.4M 1.44% 2,141,697
RARX
18
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$29.2M 1.3% 5,493,636 +2,000,000 +57% +$10.6M
DERM
19
DELISTED
Dermira, Inc.
DERM
$28M 1.25% 3,506,649
KA
20
DELISTED
Kineta, Inc. Common Stock
KA
$26.4M 1.17% 5,556,778
GNCA
21
DELISTED
Genocea Biosciences, Inc.
GNCA
$26.3M 1.17% +25,000,000 New +$26.3M
AUPH icon
22
Aurinia Pharmaceuticals
AUPH
$1.58B
$25M 1.11% 4,808,483
VRNA
23
Verona Pharma
VRNA
$9.16B
$24.4M 1.09% 1,219,674
LXRX icon
24
Lexicon Pharmaceuticals
LXRX
$400M
$20.4M 0.91% 2,382,286
CTIC
25
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$14.6M 0.65% +3,750,000 New +$14.6M